NO.1 PHARMACY released its performance for the first three quarters, with a net profit attributable to the parent company of 53.27 million yuan, a year-on-year decrease of 63.84%
According to the Zhitong Finance APP, NO.1 PHARMACY disclosed its third-quarter report for 2025. The company achieved revenue of 1.539 billion yuan in the first three quarters, a year-on-year increase of 12.43%; the net profit attributable to the parent company was 53.27 million yuan, a year-on-year decrease of 63.84%; the net profit excluding non-recurring gains and losses was 9.64 million yuan, a year-on-year increase of 23.36%; the basic earnings per share were 0.2388 yuan
According to the Zhitong Finance APP, NO.1 PHARMACY (600833.SH) disclosed its third-quarter report for 2025. The company achieved a revenue of 1.539 billion yuan in the first three quarters, a year-on-year increase of 12.43%; the net profit attributable to shareholders was 53.27 million yuan, a year-on-year decrease of 63.84%; the net profit excluding non-recurring gains and losses was 9.64 million yuan, a year-on-year increase of 23.36%; the basic earnings per share were 0.2388 yuan
